Antihypertensive Therapy with Adrenergic Beta-receptor Blockers and Vasodilators

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1972 Jun 1

PMID 4144064

Citations 7

Authors

W Aenishanslin

U C Dubach

P R Imhof

M Turri

Affiliations

Soon will be listed here.

Citing Articles

Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.

Majid P, Meeran M, Benaim M, Sharma B, Taylor S Br Heart J. 1974; 36(6):588-96.

PMID: 4850484 PMC: 458864. DOI: 10.1136/hrt.36.6.588.

Beta-adrenergic receptor blocking drugs in hypertension.

Simpson F Drugs. 1974; 7(1):85-105.

PMID: 4152167 DOI: 10.2165/00003495-197407010-00006.

Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension.

Winchester J, Ward D, McKillop J, Kennedy A Br J Clin Pharmacol. 1976; 3(5):863-7.

PMID: 788759 PMC: 1428937. DOI: 10.1111/j.1365-2125.1976.tb00639.x.

Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Motolese M, MUIESAN G, Colombi A Eur J Clin Pharmacol. 1975; 8(1):21-31.

PMID: 786673 DOI: 10.1007/BF00616411.

Altered renin release and propranolol potentiation of vasodilatory drug hypotension.

PETTINGER W, Keeton K J Clin Invest. 1975; 55(2):236-43.

PMID: 236325 PMC: 301742. DOI: 10.1172/JCI107927.

References

Campus S, Rappelli A, Fabris F, MATHIS I . [Effects of 1-4-dihydrazinophthalazine on arterial pressure and heart rate, before and after administration of beta-blocking drugs]. Boll Soc Ital Biol Sper. 1967; 43(24):1847-51. View

Brunner H, HEDWALL P, Meier M . Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine. Br J Pharmacol Chemother. 1967; 30(1):123-33. PMC: 1557245. DOI: 10.1111/j.1476-5381.1967.tb02118.x. View

Gilmore E, Weil J, CHIDSEY C . Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970; 282(10):521-7. DOI: 10.1056/NEJM197003052821001. View

Prichard B, GILLAM P . Treatment of hypertension with propranolol. Br Med J. 1969; 1(5635):7-16. PMC: 1981816. DOI: 10.1136/bmj.1.5635.7. View

Dahr A, George C, Dollery C . The effect of selective cardiac adrenergic beta-blockade on the hypotensive effect of hydrallazine. Experientia. 1971; 27(5):545-6. DOI: 10.1007/BF02147591. View

KATILA M, FRICK M . Combined dihydralazine and propranolol in the treatment of hypertension. Int Z Klin Pharmakol Ther Toxikol. 1970; 4(1):111-4. View

SANNERSTEDT R, Stenberg J, Johnsson G, WERKO L . Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man. Am J Cardiol. 1971; 28(3):316-20. DOI: 10.1016/0002-9149(71)90120-2. View

SANNERSTEDT R, Stenberg J, Vedin A, Wilhelmsson C, WERKO L . Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment. Am J Cardiol. 1972; 29(5):718-23. DOI: 10.1016/0002-9149(72)90176-2. View

Molzahn M, DISSMANN T, Gotzen R, LOHMANN F . [Effects of acute and chronic diminution of cardiac output on blood pressure in early hypertention. Hemodynamic alterations after beta-receptor blockade]. Klin Wochenschr. 1971; 49(8):476-84. DOI: 10.1007/BF01485299. View

10.

Brunner H, HEDWALL P, Maier R, Meier M . Pharmacological aspects of oxprenolol. Postgrad Med J. 1970; :Suppl:5-14. View

11.

Majid P, Sharma B, Saxton C, Stoker J, Taylor S . Haemodynamic effects of oxprenolol in hypertensive patients. Postgrad Med J. 1970; :Suppl:67-72. View